• Publications
  • Influence
Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia
Acellular vaccines against Bordetella pertussis were introduced in Australia in 1997. By 2000, these vaccines had replaced whole-cell vaccines. During 2008–2012, a large outbreak of pertussisExpand
  • 126
  • 15
  • PDF
Factors associated with HPV vaccine uptake in teenage girls: a systematic review.
BACKGROUND Since 2006 Human papillomavirus (HPV) vaccination has become available to adolescent girls and women in an increasing number of countries, to protect against the virus causing cervicalExpand
  • 332
  • 13
In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase.
To date there is compelling in vitro and in vivo evidence for epidermal H2O2 accumulation in vitiligo. This paper reviews the literature and presents new data on oxidative stress in the epidermalExpand
  • 340
  • 9
A cross‐sectional survey to assess community attitudes to introduction of Human Papillomavirus vaccine
Objective: A vaccine to prevent human papilloma virus (HPV) infection has been licensed recently in the United States of America and Australia. The aim of this study was to assess community attitudesExpand
  • 124
  • 9
Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.
CONTEXT In the ongoing influenza pandemic, a safe and effective vaccine against 2009 influenza A(H1N1) is needed for infants and children. OBJECTIVE To assess the immunogenicity and safety of aExpand
  • 206
  • 7
Healthcare providers’ knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study
BackgroundHealthcare provider spontaneous reporting of suspected adverse events following immunisation (AEFI) is central to monitoring post-licensure vaccine safety, but little is known about howExpand
  • 30
  • 6
  • PDF
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2
BACKGROUND Neisseria meningitidis serogroup B is a major cause of invasive meningococcal disease, but a broadly protective vaccine is not currently licensed. A bivalent recombinant factor H-bindingExpand
  • 126
  • 5
Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination.
Rotavirus vaccine for infants was introduced into the National Immunisation Program in Australia in July 2007. To determine the impact of rotavirus vaccination on gastroenteritis hospitalisationsExpand
  • 53
  • 4
Randomized trial of marker-directed versus standard schedule zoledronic acid for bone metastases from breast cancer.
511 Background: Zoledronic acid (ZOL) reduces skeletal morbidity associated with metastatic bone disease by 30-50%. Current recommendations are for indefinite administration of intravenous 3-4 weeklyExpand
  • 29
  • 4
Understanding the school community’s response to school closures during the H1N1 2009 influenza pandemic
BackgroundDuring the 2009 H1N1 influenza pandemic, Australian public health officials closed schools as a strategy to mitigate the spread of the infection. This article examines school communities’Expand
  • 52
  • 4
  • PDF